4.4 Article

Occurrence of multidrug-resistant and ESBL-producing atypical enteropathogenic Escherichia coli in China

Journal

GUT PATHOGENS
Volume 10, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/s13099-018-0234-0

Keywords

Enteropathogenic E. coli; Antimicrobial resistance; Multidrug resistance; ESBL

Funding

  1. National Natural Science Foundation of China [81772152, 81701977]
  2. State Key Laboratory of Infectious Disease Prevention and Control [2015SKLID504]
  3. National Basic Research Priorities Program of China [2015CB554201]

Ask authors/readers for more resources

Background: Atypical enteropathogenic Escherichia coli (aEPEC) is regarded as a globally emerging enteropathogen. aEPECs exhibit various level of resistance to a range of antibiotics, which is increasing alarmingly. The present study investigated the antimicrobial resistance of aEPEC isolates recovered from diarrheal patients, healthy carriers, animals, and raw meats. Results: Among 267 aEPEC isolates, 146 (54.7%) were resistant to tetracycline, followed by ampicillin (49.4%), streptomycin (46.1%), and piperacillin (41.2%). Multidrug resistance (MDR) was detected in 128 (47.9%) isolates, and 40 MDR isolates were resistant to >= 10 antimicrobial agents. A total of 47 (17.6%) aEPEC isolates were identified as extended-spectrum beta-lactamase (ESBL)-producers. The bla(CTX-M-14) and bla(CTX-M-15) genes were predominant among ESBL-producing isolates. Conclusions: This investigation depicted the occurrence of multidrug-resistant and ESBL-producing aEPEC isolates in China. The results suggested that it is necessary to continuously monitor the emergence and spread of MDR aEPEC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available